These analyses revealed significantly higher CERS4 mRNA expression levels in tumor tissues than in normal tissues in two cohorts (TCGA-BRCA, P < 0.0001; GSE115577, P < 0.0001; Fig. 1A). The gene discussed is CERS4; the disease is neoplasm.